Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Programa sobre Trastorno Bipolar del 26 ECNP Barcelona 2013

284 views

Published on

Programa sobre Trastorno Bipolar del 26 ECNP Barcelona 2013
Más información en www.puedoser.es

Published in: Health & Medicine
  • Be the first to comment

  • Be the first to like this

Programa sobre Trastorno Bipolar del 26 ECNP Barcelona 2013

  1. 1. C.03: Prioritising the patient in the management ofmajor depressive disorderEducational financial support provided by AstraZenecaSaturday 15:45 - 17:30Room: Room HChairKoen Demyttenaere, BelgiumPresentationsC.03.01: How confidently can we predict response in patients with MDD?Philip Gorwood, FranceC.03.02: From hopelessness to hope: a patient-centred approachHamish McAllister-Williams, United KingdomC.03.03: New pharmacotherapeutic opportunities for the treatment ofdepressionBrian Leonard, IrelandSession TypeSatellite symposiumC.08: Bipolar disorder: the evolving storyEducational financial support provided by AstraZenecaSunday 16:45 - 18:30Room: Room JChairRoger McIntyre, CanadaPresentationsC.08.01: Improving patient outcomes in bipolar disorderEduard Vieta, SpainC.08.02: A disease for life? Beyond acute episodes in bipolar disorderGuy Goodwin, United KingdomSession TypeSatellite symposiumC.13: The multidimensional perspective of Bipolar IdisorderMonday 16:45 - 18:30Room: Room M2ChairAndrea Fagiolini, ItalyPresentations
  2. 2. C.13.01: The manic depressive spectrum, the DSM5 perspectiveAndrea Fagiolini, ItalyC.13.02: Bipolar mixed states, recognition and courseAllan H. Young, United KingdomC.13.03: Treatment of mixed statesMichael Berk, AustraliaSession TypeSatellite symposiumS.25: Genetic implications in bipolar disorderWednesday 09:00 - 10:40Room: AuditoriumChairIstván Bitter, HungaryPresentations09:00-09:25S.25.01: Pharmacogenetics of antidepressant, antiepileptic and neurolepticdrug treatmentLeif Bertilsson, Sweden09:25-09:50S.25.02: Molecular genetic aspects to serotonergic drugs in bipolar disorderXenia Gonda, Hungary09:50-10:15S.25.03: Pharmacogenetics of efficacy and treatment side effects in bipolardisorderAlessandro Serretti, Italy10:15-10:40S.25.04: Genetics of suicidal behaviour in bipolar disorder: an updateAntoni Benabarre, SpainSession TypeSymposiumTrackClinical Treatment trackS.25: Genetic implications in bipolar disorderWednesday 09:00 - 10:40Room: AuditoriumChairIstván Bitter, HungaryPresentations09:00-09:25S.25.01: Pharmacogenetics of antidepressant, antiepileptic and neurolepticdrug treatmentLeif Bertilsson, Sweden09:25-09:50S.25.02: Molecular genetic aspects to serotonergic drugs in bipolar disorder
  3. 3. Xenia Gonda, Hungary09:50-10:15S.25.03: Pharmacogenetics of efficacy and treatment side effects in bipolardisorderAlessandro Serretti, Italy10:15-10:40S.25.04: Genetics of suicidal behaviour in bipolar disorder: an updateAntoni Benabarre, Spain

×